Every 10-Q that LFTD PARTNERS INC (LIFD) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow LIFD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LIFD filings page.
LFTD Partners Inc. reported sharply weaker results for the six months ended June 30, 2026 and disclosed substantial doubt about its ability to continue as a going concern. Net sales were $17,863,400, down from $19,449,186 a year earlier, and cost of goods sold rose to $18,918,247, producing a gross loss of $1,054,847.
The company recorded a large $6,596,096 inventory reserve, including $5,007,427 against hemp-derived products and $1,434,458 against kratom-derived inventory, driving a six‑month net loss of $5,598,239 and reducing shareholders’ equity to $7,027,327. Cash was $1,504,297 and total assets fell to $12,026,907.
Management states that LFTD is completely dependent on subsidiary Lifted and that federal actions targeting intoxicating hemp-derived products (effective November 12, 2026) and 7‑OH kratom products could eliminate its two major lines of business. The company has laid off staff to about 77 people, agreed to sell its Kenosha facility for $1,500,000 to repay an $836,358 Surety Bank mortgage, impaired its Bendistillery investment to zero, and is pursuing diversification into hemp‑free gummies and potential acquisitions of multifamily properties and laundromats, while warning there is no assurance these initiatives will succeed.
LFTD Partners Inc. reported Q1 2026 net sales of $9.16M, roughly flat year over year, but recorded a net loss of $4.16M versus $0.30M a year earlier. The loss was driven mainly by a new inventory reserve of $5.06M, including $4.72M against hemp-derived products and $0.34M against 7-hydroxymitragynine inventory, plus a $0.14M impairment of hemp-specific fixed assets.
The company warns that a U.S. law banning intoxicating hemp-derived consumables effective November 12, 2026 could eliminate roughly half or more of revenue and has already led to goodwill and investment impairments in 2025. Management states there is substantial doubt about the company’s ability to continue as a going concern. At March 31, 2026, cash was $2.09M, total assets were $14.45M, liabilities were $5.98M, and shareholders’ equity was $8.47M.
LFTD Partners (LIFD) reported a profitable Q3 2025, with net sales of $9,056,742 and net income of $634,257, reversing a loss a year ago. Gross profit rose to $4,157,495 on lower operating expenses, lifting income from operations to $1,312,791.
For the nine months, net sales were $28,505,928 and net income was $62,265. Cash and cash equivalents were $1,920,664, with restricted cash of $1,000,000. The company reduced Surety Bank borrowings during Q3, including a $592,050 paydown on its working capital loan. Shares outstanding were 14,822,678 as of November 13, 2025.
Risks increased materially. On November 12, 2025, a federal act was signed that bans intoxicating hemp-derived consumable products nationally on November 12, 2026. Hemp-derived products accounted for approximately 47% of Q3 sales. Management warns the act could trigger goodwill impairments on total goodwill of $23,092,794, potential impairment of a $399,200 investment, and significant inventory write-offs. The company states there is substantial doubt about its ability to continue as a going concern.